ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,434, issued on Feb. 24, was assigned to The Trustees of the University of Pennsylvania (Philadelphia) and REGENX BIO INC (Rockville, Md.).

"Compositions for treatment of wet age-related macular degeneration" was invented by James M. Wilson (Philadelphia), Stephen Yoo (Bethesda, Md.), Sherri Van Everen (Menlo Park, Calif.), Jean Bennett (Bryn Mawr, Pa.), Albert M. Maguire (Bryn Mawr, Pa.), Tomas Santiago Aleman (Croydon, Pa.), Tristan James Marshall (Potomac, Md.) and Anna Tretiakova (Philadelphia).

According to the abstract* released by the U.S. Patent & Trademark Office: "A liquid suspension product comprising a recombinant adeno-associated virus (rAAV) having an AAV8 capsid whi...